18F-FDG-PET in assessing disease activity in takayasu arteritis: A meta-analysis

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.75, 2013, Pages

  Cheng, Yanmei ^a   Lv, Naqiang ^a   Wang, Zhiguang ^a   Chen, Bingwei ^a   Dang, Aimin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

18F FDG; Meta analysis; PET; Takayasu arteritis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AORTA ARCH SYNDROME; ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; META ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; FEMALE; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; REVIEW; SCINTISCANNING; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 84878421825     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. NUMANO F, OKAWARA M, INOMATA H, KOBAYASHI Y: Takayasu's arteritis. Lancet 2000; 356: 1023-5.
2. KERR GS, HALLAHAN CW, GIORDANO J et al.: Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.
3. HOFFMAN GS, AHMED AE: Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998; 66 (Suppl. 1): S191-4; discussion S5.
4. FORSTROM LA, MULLAN BP, HUNG JC, LOWE VJ, THORSON LM: 18F-FDG labelling of human leukocytes. Nucl Med Commun 2000; 21: 691-4.
5. FORSTROM LA, DUNN WL, MULLAN BP, HUNG JC, LOWE VJ, THORSON LM: Biodistribution and dosimetry of [(18)F]fluorodeo xyglucose labelled leukocytes in normal human subjects. Nucl Med Commun 2002; 23: 721-5.
6. ANDREWS J, AL-NAHHAS A, PENNELL DJ et al.: Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 2004; 63: 995-1000.
7. TALARICO R, BALDINI C, DELLA ROSSA A et al.: Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature. Clin Exp Rheumatol 2012; 30 (Suppl. 70):S130-8.
8. GERMANO G, VERSARI A, MURATORE F et al.: Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S138-9.
9. BEJERANO C, BLANCO R, GONZALEZ-VELA C, AGUERO R, CARRIL JM, GONZALEZ-GAY MA: Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab. Clin Exp Rheumatol 2012; 30 (Suppl. 70): S94-7.
10. BEJERANO C, BLANCO R, GONZALEZ-VELA C et al.: Polymyalgia rheumatica as presenting manifestation of vasculitis involving the lower extremities in a patient with ulcerative colitis. Clin Exp Rheumatol 2012; 30 (Suppl. 70): S110-3.
11. WHITING P, RUTJES AW, REITSMA JB, BOSSUYT PM, KLEIJNEN J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
12. LITTENBERG B, MOSES LE: Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993; 13: 313-21.
13. ZAMORA J, ABRAIRA V, MURIEL A, KHAN K, COOMARASAMY A: Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
14. TEZUKA D, HARAGUCHI G, ISHIHARA T et al.: Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012; 5: 422-9.
15. WALTER MA, MELZER RA, SCHINDLER C, MULLER-BRAND J, TYNDALL A, NITZSCHE EU: The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assess-ment of activity and extent of disease. Eur J Nucl Med Mol Imagin 2005; 32: 674-81.
16. RICALDE-ALCOCER A, SOTO-LOPEZ ME, REYES P et al.: Pet evaluation of inflammatory process in Takayasu's arteritis. Archivos de Cardiologia de Mexico 2010; 80: 235- 41.
17. LEE SG, RYU JS, KIM HO et al.: Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis. Clin Nucl Med 2009; 34: 749-52.
18. LEE KH, CHO A, CHOI YJ et al.: The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis. Arthritis Rheum 2012; 64: 866-75.
19. ARNAUD L, HAROCHE J, MALEK Z et al.: Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 2009; 60: 1193-200.
20. KOBAYASHI Y, ISHII K, ODA K et al.: Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005 Jun; 46: 917-22.
21. WEBB M, CHAMBERS A, AL-NAHHAS A et al.: The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004; 31: 627- 34.
22. VISTA EG, SANTOS ESTRELLA PV, LICHAUCO JJ: Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis - A report of four cases. Autoimmun Rev 2010; 9: 503-6.
23. MELLER J, GRABBE E, BECKER W, VOSSHENRICH R: Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003; 13: 400-5.
24. BESSON FL, PARIENTI JJ, BIENVENU B et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011; 38: 1764-72.
25. HOFFMAN GS: Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol 1996; 54 (Suppl.): S99-102.
26. AREND WP, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129- 34.
27. BLOCKMANS D, DE CEUNINCK L, VANDERSCHUEREN S, KNOCKAERT D, MORTELMANS L, BOBBAERS H: Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55: 131-7.
28. MASTELING MG, ZEEBREGTS CJ, TIO RA et al.: High-resolution imaging of human atherosclerotic carotid plaques with micro 18FFDG PET scanning exploring plaque vulnerability. J Nucl Cardiol 2011; 18: 1066-75.
29. IWABU M, YAMAMOTO Y, DOBASHI H, KAMEDA T, KITTAKA K, NISHIYAMA Y: F-18 FDG PET findings of Takayasu arteritis before and after immunosuppressive therapy. Clin Nucl Med 2008; 33: 872-3.
30. BOTH M, AHMADI-SIMAB K, REUTER M et al.: MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008; 67: 1030-3.
31. WALTER MA, MELZER RA, GRAF M, TYNDALL A, MULLER-BRAND J, NITZSCHE EU: [18F]FDG-PET of giant-cell aortitis. Rheumatology (Oxford) 2005; 44: 690-1.
32. LEHMANN P, BUCHTALA S, ACHAJEW N et al.: 18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol 2011; 30: 37-42.